Impact of point-of-care testing in the emergency department evaluation and treatment of patients with suspected acute coronary syndromes

Academic Emergency Medicine

Volumn 15, Issue 3, 2008, Pages 216-224

  Renaud, Bertrand ^a,b   Maison, Patrick ^a,b   Ngako, Alfred ^a,b   Cunin, Patrick ^a,b   Santin, Aline ^a,b   Hervé, Jérôme ^a,b   Salloum, Mirna ^a,b   Calmettes, Marie Jeanne ^a,b   Boraud, Cyril ^a,b   Lemiale, Virginie ^a,b   Grégo, Jean Claude ^a,b   Debacker, Marie ^a,b   Hémery, François ^a,b   Roupie, Eric ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

Author keywords

Coronary artery disease; Emergency medicine; Myocardial infarction; Point of care systems; Randomized controlled trials; Troponin

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LOW MOLECULAR WEIGHT HEPARIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; POINT OF CARE TESTING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; BLOOD; EMERGENCY HEALTH SERVICE; FOLLOW UP; HOSPITAL INFORMATION SYSTEM; MIDDLE AGED; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADULT; AGED; EMERGENCY SERVICE, HOSPITAL; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POINT-OF-CARE SYSTEMS; TROPONIN I;

EID: 48949120287     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2008.00069.x     Document Type: Article

References (48)

1. Luepker RV, Raczynski JM, Osganian S, et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. JAMA. 2000; 284:60-7.
2. Tricoci P, Lokhnygina Y, Berdan LG, et al. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes. Results from the SYNERGY Trial. Circulation. 2007; 116:2669-77.
3. Neumann FJ, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA. 2003; 290:1593-9.
4. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J. 2007; 28:1598-660.
5. Canto JG, Fincher C, Kiefe CI, et al. Atypical presentations among Medicare beneficiaries with unstable angina pectoris. Am J Cardiol. 2002; 90:248-53.
6. Culic V, Eterovic D, Miric D, Silic N. Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors. Am Heart J. 2002; 144:1012-7.
7. Brieger D, Eagle KA, Goodman SG, et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest. 2004; 126:461-9.
8. Gibler WB, Cannon CP, Blomkalns AL, et al. Practical implementation of the guidelines for unstable angina?non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration with the Society of Chest Pain Centers. Circulation. 2005; 111:2699-710.
9. Apple FS, Ler R, Chung AY, Berger MJ, Murakami MM. Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome. Clin Chem. 2006; 52:322-5.
10. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002; 23:1809-40.
11. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem. 1999; 45:1104-21.
12. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 1997; 337:1648-53.
13. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina?non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000; 284:835-42.
14. Bhatt DL, Roe MT, Peterson ED, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004; 292:2096-104.
15. Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med. 2004; 141:186-95.
16. Alexander KP, Newby LK, Cannon CP, et al. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007; 115:2549-69.
17. Mehta SR, Cannon CP, Fox KA, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005; 293:2908-17.
18. de Winter RJ, Windhausen F, Cornel JH, et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med. 2005; 353:1095-104.
19. Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J. 2002; 23:1153-76.
20. Harrington RA, Becker RC, Ezekowitz M, et al. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3 Suppl):513S-548S.
21. Kendall J, Reeves B, Clancy M. Point of care testing: randomised controlled trial of clinical outcome. BMJ. 1998; 316:1052-7.
22. Singer AJ, Ardise J, Gulla J, Cangro J. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann Emerg Med. 2005; 45:587-91.
23. Leman P, Guthrie D, Simpson R, Little F. Improving access to diagnostics: an evaluation of a satellite laboratory service in the emergency department. Emerg Med J. 2004; 21:452-6.
24. Wu AH. Point of care testing for conventional cardiac markers. Point of Care: J Near-Patient Test Technol. 2006; 5:20-4.
25. McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation. 2001; 104:1483-8.
26. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003; 24:28-66.
27. Pascal P, Beyerle F. [Quality standards for medical laboratories]. Pathol Biol (Paris). 2006; 54:317-24.
28. The Joint European Society of Cardiology?American College of Cardiology. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology?American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000; 21:1502-13.
29. Heeschen C, Goldmann BU, Langenbrink L, Matschuck G, Hamm CW. Evaluation of a rapid whole blood ELISA for quantification of troponin I in patients with acute chest pain. Clin Chem. 1999; 45:1789-96.
30. Christenson RH, Cervelli DR, Bauer RS, Gordon M. Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentrations. Clin Biochem. 2004; 37:679-83.
31. Beneteau-Burnat B, Baudin B, Vaubourdolle M. Evaluation of Stratus CS stat fluorimetric analyser for measurement of cardiac markers Troponin I (cTnI), creatine kinase MB (CK-MB), and myoglobin. J Clin Lab Anal. 2001; 15:314-8.
32. Hafner G, Peetz D, Dati F, et al. Analytical and clinical evaluation of troponin I determination on dimension RXL-HM. Clin Chem Lab Med. 2000; 38:355-61.
33. Spacek R, Widimsky P, Straka Z, et al. Value of first day angiography?angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. Eur Heart J. 2002; 23:230-8.
34. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002; 90:358-63.
35. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002; 23:1190-201.
36. Delaney B, Wilson S, Fitzmaurice D, Hyde C, Hobbs R. Near-patient tests in primary care: setting the standards for evaluation. J Health Serv Res Policy. 2000; 5:37-41.
37. Coronado BE, Pope JH, Griffith JL, Beshansky JR, Selker HP. Clinical features, triage, and outcome of patients presenting to the ED with suspected acute coronary syndromes but without pain: a multicenter study. Am J Emerg Med. 2004; 22:568-74.
38. Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000; 283:3223-9.
39. Parvin CA, Lo SF, Deuser SM, Weaver LG, Lewis LM, Scott MG. Impact of point-of-care testing on patients' length of stay in a large emergency department. Clin Chem. 1996; 42:711-7.
40. Fleisher M, Schwartz MK. Automated approaches to rapid-response testing. A comparative evaluation of point-of-care and centralized laboratory testing. Am J Clin Pathol. 1995; 4 Suppl(1):S18-25.
41. Saxena S, Wong ET. Does the emergency department need a dedicated stat laboratory? Continuous quality improvement as a management tool for the clinical laboratory. Am J Clin Pathol. 1993; 100:606-10.
42. Collinson PO, John C, Lynch S, et al. A prospective randomized controlled trial of point-of-care testing on the coronary care unit. Ann Clin Biochem. 2004; 41(Pt 5):397-404.
43. Brogan GX Jr, Bock JL. Cardiac marker point-of-care testing in the emergency department and cardiac care unit. Clin Chem. 1998; 44(8 Pt 2):1865-9.
44. Newby K. Clinical outcomes according to time to treatment. Clin Cardiol. 1997; 20(11 Suppl 3):III11-5.
45. Ryan JW, Peterson ED, Chen AY, et al. Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC?AHA guidelines) Registry. Circulation. 2005; 112:3049-57.
46. Christenson J, Innes G, McKnight D, et al. A clinical prediction rule for early discharge of patients with chest pain. Ann Emerg Med. 2006; 47:1-10.
47. Apple FS, Chung AY, Kogut ME, Bubany S, Murakami MM. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clin Chim Acta. 2006; 370:191-5.
48. Collinson PO. Testing for cardiac markers at the point of care. Clin Lab Med. 2001; 21:351-62.